Table 1:

Control CSF samples (sorted by age at collection)

Age (years)SexReason for LP
0.08MRespiratory syncytial virus bronchiolitis
0.08FAcute respiratory failure
0.12FAcute life-threatening event
0.66MVomiting
2.16FGastrointestinal virus
2.25MLymphoma
3.08MDiGeorge syndrome
3.75FAcute lymphocytic leukemia/chemotherapy evaluation
3.92MAcute lymphocytic leukemia/chemotherapy evaluation
4.08MAcute lymphocytic leukemia/chemotherapy evaluation
4.33MAcute lymphocytic leukemia/chemotherapy evaluation
5.25MAcute lymphocytic leukemia/chemotherapy evaluation
5.33MAcute lymphocytic leukemia
5.75MAcute lymphocytic leukemia/chemotherapy evaluation
6.92FAcute lymphocytic leukemia/chemotherapy evaluation
9.25MAcute lymphocytic leukemia/chemotherapy evaluation
9.58FEhlers-Danlos syndrome, mental status change
12.33MAcute lymphocytic leukemia/chemotherapy evaluation
14.16FAcute lymphocytic leukemia/chemotherapy evaluation
14.75FAcute lymphocytic leukemia/chemotherapy evaluation
15.33FIdiopathic intracranial hypertension
16.66MAcute lymphocytic leukemia/chemotherapy evaluation
17.33MAcute lymphocytic leukemia/chemotherapy evaluation
19MAcute lymphocytic leukemia/chemotherapy evaluation
  • Deidentified control CSF samples are tabulated indicating sex and the clinical reason for LP. Age at collection is given in years. F, Female; M, male.